An Observational Study to Assess the Effect of the Accu-Chek® SugarView app (based on app version 4.0.3) on Diabetes Empowerment of Subjects with Type 2 Diabetes Mellitus (BEAT Accu-Chek SugarView India Study)

Roche Diabetes Care India Pvt Ltd0 个研究点目标入组 100 人开始时间: 待定最近更新: 2023年11月13日

试验速览

暂无简介。

•1. Subject has provided his/her signed informed consent.
•2. Subject is = 18 years of age
•3. Subject is diagnosed with diabetes type 2 and currently on exercise, diet or single or dual agent anti-diabetic therapy (but not on insulin and anti-diabetic drug with an hypoglycemic risk profile such as sulfonylureas)
•4. Need to be empowered for disease self-management
•5. Willingness to adhere to the app
•- Never used a blood glucose meter for self-testing of blood glucose before (SMBG naive)
•6. Subject must have and can use a smartphone, and should complete training on usage of the application installed in smartphone
•7. Subjects who are able to read and write in English language
•8. Willing to participate in the study and comply with study procedures
•9. Provide study demographics such as age, education level, gender, therapy type and occupation
•10. Experienced in using apps; and were currently using apps installed on their smartphones

•1. Subject is pregnant or breastfeeding
•2. Subject has incarceration or vision impairment not correctable with glasses or contact lenses
•3. Subject is diagnosed with any clinically significant condition (e.g. infectious disease,
•major organ system disease, such as gastroparesis or renal disease, psychosis or cognitive impairment), at investigator’s discretion
•4. Subject does undergo chemotherapy or radiation therapy (self-reported)
•5. Subject is related to the investigator or research staff
•6. Subject is using any other mobile device to monitor glucose levels
•7. Subject shares phones with other persons

发起方

Roche Diabetes Care India Pvt Ltd